Narrative review / 2013
Curcumin shows potential in clinical studies for preventing or treating colonic diseases such as ulcerative colitis, Crohn's disease, and colonic cancer.
This review discusses the pharmacology, pharmacokinetics, and clinical evidence regarding curcumin for colonic diseases. Studies suggest curcumin possesses anti-inflammatory, anticancer, and antioxidant properties, functioning as a potential candidate for treating ulcerative colitis, Crohn's disease, and colonic cancer. However, achieving optimum therapeutic levels remains challenging due to curcumin's low solubility and poor bioavailability, prompting development of novel delivery systems to improve absorption.
- Study type
- Narrative review
- Who was studied
- Patients with colonic diseases (clinical studies discussed in review)
- What was measured
- Prevention and treatment of colonic diseases, bioavailability of curcumin
THE PAPER
Curcumin: a boon to colonic diseases.
Sareen R, Jain N, Pandit V. Curr Drug Targets, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.